DePuy Synthes receives FDA 510(k) clearance of robotic-assisted UKA platform

DePuy Synthes announced it received FDA 510(k) clearance for the Velys robotic-assisted unicompartmental knee arthroplasty platform, according to a press release.
The Velys UKA platform is designed with robotic guidance to assist in implant positioning without the need for CT scans. The platform previously received FDA clearance for total knee arthroplasty and is now cleared for use in both medial and lateral UKA, according to the release.
“We are committed to continually improving and expanding the capabilities and user experience of our Velys-enabling technology portfolio,” Aldo

DePuy Synthes announced it received FDA 510(k) clearance for the Velys robotic-assisted unicompartmental knee arthroplasty platform, according to a press release.
The Velys UKA platform is designed with robotic guidance to assist in implant positioning without the need for CT scans. The platform previously received FDA clearance for total knee arthroplasty and is now cleared for use in both medial and lateral UKA, according to the release.
“We are committed to continually improving and expanding the capabilities and user experience of our Velys-enabling technology portfolio,” Aldo